Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Atara Biotherapeutics, Inc. - Common Stock
(NQ:
ATRA
)
4.620
-1.260 (-21.43%)
Streaming Delayed Price
Updated: 12:26 PM EST, Jan 13, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Atara Biotherapeutics, Inc. - Common Stock
< Previous
1
2
...
4
5
6
7
8
9
10
11
Next >
Atara Biotherapeutics Announces Second Quarter 2023 Financial Results and Operational Progress
August 08, 2023
From
Atara Biotherapeutics, Inc.
Via
Business Wire
Atara Biotherapeutics's Earnings Outlook
↗
August 07, 2023
Via
Benzinga
Atara Biotherapeutics, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
August 04, 2023
From
Atara Biotherapeutics, Inc.
Via
Business Wire
Atara Biotherapeutics to Announce Second Quarter 2023 Financial Results on Tuesday, August 8, 2023
August 01, 2023
From
Atara Biotherapeutics, Inc.
Via
Business Wire
Atara Biotherapeutics Earnings Perspective: Return On Capital Employed
↗
May 23, 2023
Via
Benzinga
Atara Biotherapeutics to Participate in the Canaccord Genuity 43rd Annual Growth Conference
July 31, 2023
From
Atara Biotherapeutics, Inc.
Via
Business Wire
3 Doomed Biotech Stocks Destined for Disaster
↗
July 17, 2023
Doomed biotech stocks are a major part of the natural cycle within the sector that results in a lot of failures.
Via
InvestorPlace
Atara Biotherapeutics, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
July 07, 2023
From
Atara Biotherapeutics, Inc.
Via
Business Wire
A Preview Of Atara Biotherapeutics's Earnings
↗
May 05, 2023
Via
Benzinga
Looking Into Atara Biotherapeutics's Return On Capital Employed
↗
February 10, 2023
Via
Benzinga
Atara Biotherapeutics to Participate in the Goldman Sachs 44th Annual Global Healthcare Conference
June 07, 2023
From
Atara Biotherapeutics, Inc.
Via
Business Wire
Atara Biotherapeutics Presents Updated Tab-cel® Clinical Effectiveness Data at ASCO 2023
June 05, 2023
From
Atara Biotherapeutics, Inc.
Via
Business Wire
Atara Biotherapeutics, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
June 02, 2023
From
Atara Biotherapeutics, Inc.
Via
Business Wire
Why PRA Group Shares Are Trading Lower By 44%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
↗
May 09, 2023
Gainers TScan Therapeutics, Inc. (NASDAQ: TCRX) shares gained 118% to $4.68 after the company and Amgen announced collaboration to identify novel targets in Crohn's disease.
Via
Benzinga
Atara Biotherapeutics Announces First Quarter 2023 Financial Results and Operational Progress
May 08, 2023
From
Atara Biotherapeutics, Inc.
Via
Business Wire
Atara Biotherapeutics, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 05, 2023
From
Atara Biotherapeutics, Inc.
Via
Business Wire
Atara Biotherapeutics to Announce First Quarter 2023 Financial Results on Monday, May 8, 2023
May 01, 2023
From
Atara Biotherapeutics, Inc.
Via
Business Wire
3 Stocks to Buy That Could Be the Next Biotech Breakthrough
↗
April 16, 2023
Biotech stocks are highly speculative, but it's possible to choose ones with excellent risk-reward ratios.
Via
InvestorPlace
Atara Biotherapeutics, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
March 31, 2023
From
Atara Biotherapeutics, Inc.
Via
Business Wire
Atara Biotherapeutics, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
March 03, 2023
From
Atara Biotherapeutics, Inc.
Via
Business Wire
Atara Biotherapeutics to Participate in Cell Therapy Panel Discussion at the Cowen 43rd Annual Health Care Conference
March 01, 2023
From
Atara Biotherapeutics, Inc.
Via
Business Wire
Atara Biotherapeutics to Participate in the H.C. Wainwright Cell Therapy Virtual Conference
February 21, 2023
From
Atara Biotherapeutics, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Wednesday's After-Market Session
↗
February 08, 2023
Via
Benzinga
Atara Biotherapeutics Announces Fourth Quarter and Full Year 2022 Financial Results and Operational Progress
February 08, 2023
From
Atara Biotherapeutics, Inc.
Via
Business Wire
Pierre Fabre to Commercialize and Distribute the First Approved Allogeneic T-cell Immunotherapy in Europe Following Transfer of the European Commission Marketing Authorization of EBVALLO™ (tabelecleucel)
February 08, 2023
From
Atara Biotherapeutics, Inc.
Via
Business Wire
Why Bed Bath & Beyond Fell Almost 30%; Here Are 20 Stocks Moving Premarket
↗
February 07, 2023
Gainers
Via
Benzinga
Atara Biotherapeutics to Announce Fourth Quarter and Full Year 2022 Financial Results on Wednesday, February 8, 2023
February 06, 2023
From
Atara Biotherapeutics, Inc.
Via
Business Wire
Atara Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
February 03, 2023
From
Atara Biotherapeutics, Inc.
Via
Business Wire
Atara Biotherapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
January 13, 2023
From
Atara Biotherapeutics, Inc.
Via
Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For January 5, 2023
↗
January 05, 2023
Via
Benzinga
< Previous
1
2
...
4
5
6
7
8
9
10
11
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
